Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM Plunges 9%; BSE HEALTHCARE Index Down 1.7%
Mon, 5 Aug 11:31

NGL FINE CHM Plunges 9%; BSE HEALTHCARE Index Down 1.7%Image source: ipopba/www.istockphoto.com

NGL FINE CHM share price has plunged 9% and is presently trading at Rs 2,398.9.

Meanwhile, the BSE HEALTHCARE index is at 40,134.0 (down 1.7%).

Among the top losers in the BSE HEALTHCARE index today are HIKAL CHEMIC (down 6.4%) and CAPLIN POINT (down 6.1%).

Sun Pharma (up 0.1%) is among the top gainers today.

Over the last one year, NGL FINE CHM has moved up from Rs 2,035.8 to Rs 2,398.9, registering a gain of Rs 363.1 (up 17.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,644.7 to 40,134.0, registering a gain of 45.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 119.7%), SUVEN PHARMACEUTICALS (up 99.0%) and GSK Pharma (up 96.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,577.0 (down 3.0%).

The top losers among the BSE Sensex today are Tata Motors (down 6.9%) and Tata Steel (down 5.8%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,006.5 (down 2.9%). Tata Motors and ONGC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,459.3 to 78,577.0, registering a gain of 12,117.7 points (up 18.2%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 32.2% YoY to Rs 123 million for the quarter ended March 2024, compared to a profit of Rs 93 million a year ago. Net sales rose 35.0% to Rs 998 million during the period as against Rs 739 million in January-March 2023.

For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 35.8.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 9%; BSE HEALTHCARE Index Down 1.7%". Click here!